TipRanks
Nanobac Pharmaceuticals Incorporated (NNBP)
OTHER OTC:NNBP
US Market
NNBP
Nanobac Pharmaceuticals
RESEARCH TOOLSreports

Nanobac Pharmaceuticals (NNBP) Income Statement

6 Followers

Nanobac Pharmaceuticals Income Statement

Last quarter (Q0 0), Nanobac Pharmaceuticals's total revenue was $―, a decrease of ― from the same quarter last year. In Q0, Nanobac Pharmaceuticals's net income was $-1.17M. See Nanobac Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 07Dec 06Dec 05Dec 04Dec 03
Total Revenue
$ ―$ ―$ ―$ ―$ ―
Gross Profit
$ 3.10K$ 145.28K$ 427.36K$ 257.89K$ 149.69K
Operating Expenses
$ ―$ ―$ ―$ ―$ ―
Depreciation and Amortization
$ 460.30K$ 541.28K$ 759.93K$ 717.07K$ 181.10K
EBITDA
$ -4.45M$ -4.27M$ -2.08M$ -6.88M$ -2.52M
Operating Income
$ -4.91M$ -4.81M$ -2.84M$ -7.60M$ -2.70M
Other Income/Expenses
$ ―$ ―$ ―$ ―$ ―
Pretax Income
$ ―$ ―$ ―$ ―$ ―
Net Income
$ -6.58M$ -4.97M$ -3.69M$ -7.87M$ -3.70M
Per Share Metrics
Basic EPS
$ ―$ ―$ ―$ ―$ ―
Diluted EPS
$ ―$ ―$ ―$ ―$ ―
Weighted Average Shares Outstanding
 ― ― ― ― ―
Weighted Average Shares Outstanding (Diluted)
 ― ― ― ― ―

Nanobac Pharmaceuticals Earnings and Revenue History